DrugDashboards

Sodium Thiosulfate

Sodium Thiosulfate · SODIUM THIOSULFATE 250 mg/mL · Injection, Solution · Intravenous · Hope Pharmaceuticals

NDC 60267-0705-50 · 50 mL in 1 VIAL, SINGLE-DOSE · NDA · View full market →

The short version

Just 2 companies supply this market — thin enough that a single exit would be felt immediately. One of its named manufacturing plants, Curia New York, Inc., failed FDA inspectionwithin the last two years — the agency’s most serious outcome.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Estimated fill cost

WAC per package, as filed
$120.00
Reported to Texas DSHS · 2026 annual filing · Hope Pharmaceuticals

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program

Regulatory

Application
NDA203923
TE code
Approval date
Feb 14, 2012
Patents / exclusivity
6 patents, 0 exclusivities
TypeNumber / codeExpires
patent8496973Mar 29, 2031
patent9345724Jul 7, 2030
patent10479686Jul 7, 2030
patent9585912Jul 7, 2030
patent11753301Feb 10, 2030
patent12304813Feb 10, 2030

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Sodium Thiosulfate (Injection, Solution)

LabelerStrengthFirst seenLast seen
Fennec Pharmaceuticals Inc.SODIUM THIOSULFATE 12.5 g/100mLJul 15, 2026Sep 2, 2026
Hope PharmaceuticalsSODIUM THIOSULFATE 250 mg/mLJul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Sodium Thiosulfate — NDC 60267-0705-50," retrieved September 3, 2026, https://drugdashboards.com/drug/60267070550.

Free to cite with attribution — see how the data is put together.